Trials · 2011
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка NIH: внешняя программаНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Choi Won S, Faseru Babalola, Beebe Laura A, Greiner Allen K, Yeh Hung-Wen, Shireman Theresa I, Talawyma Myrietta, Cully Lance, Kaur Baljit, Daley Christine M
Аннотация
BACKGROUND: Cigarette smoking is the number one cause of preventable death among American Indian and Alaska Natives, AI/ANs. Two out of every five AI/AN will die from tobacco-related diseases if the current smoking rates of AI/ANs (40.8%) persist. Currently, there is no proven, effective culturally-tailored smoking cessation program designed specifically for a heterogeneous population of AI.The primary aim of this group randomized clinical trial is to test the efficacy of "All Nations Breath of Life" (ANBL) program compared to a non-tailored "Current Best Practices" smoking cessation program among AI smokers.
METHODS: We will randomize 56 groups (8 smokers per group) to the tailored program or non-tailored program for a total sample size of 448 American Indian smokers. All participants in the proposed study will be offered pharmacotherapy, regardless of group assignment. This study is the first controlled trial to examine the efficacy of a culturally-tailored smoking cessation program for American Indians. If the intervention is successful, the potential health impact is significant because the prevalence of smoking is the highest in this population.
TRIAL REGISTRATION: ClinicalTrials.gov: NCT01106456.
METHODS: We will randomize 56 groups (8 smokers per group) to the tailored program or non-tailored program for a total sample size of 448 American Indian smokers. All participants in the proposed study will be offered pharmacotherapy, regardless of group assignment. This study is the first controlled trial to examine the efficacy of a culturally-tailored smoking cessation program for American Indians. If the intervention is successful, the potential health impact is significant because the prevalence of smoking is the highest in this population.
TRIAL REGISTRATION: ClinicalTrials.gov: NCT01106456.
Предметные рубрики MeSH
BenzazepinesBupropionCounselingCultural CharacteristicsHealth BehaviorHealth Knowledge, Attitudes, PracticeHumansIndians, North AmericanKansasNicotinic AgonistsOklahomaPatient Education as TopicQuinoxalinesResearch DesignSelf-Help GroupsSmokingSmoking CessationSmoking PreventionTobacco Use DisorderTreatment OutcomeVarenicline